The Revolutionary Treatment That Could End Sleep Apnea Forever episode artwork

EPISODE · May 28, 2025 · 14 MIN

The Revolutionary Treatment That Could End Sleep Apnea Forever

from Primary Care Voice · host Kulmeet Kundlas M.D.

Breakthrough Treatment for Obstructive Sleep Apnea: FDA Approves Zepbound (Tirzepatide) #kundlasmd #shieldmedicalgroup In this video, Dr. Kulmeet kundlas discusses a major medical advancement in the treatment of obstructive sleep apnea—the FDA's approval of tirzepatide, marketed as Zepbound, in December 2024. He highlights the significant impact of sleep apnea and the limitations of traditional treatments like CPAP machines. Dr. explains how Zepbound not only treats but may cure sleep apnea by addressing underlying metabolic issues, helping patients lose weight, and improving overall health. He also covers the pathophysiology, diagnosis, risk factors, and alternative treatments for obstructive sleep apnea, emphasizing the vital role of a healthy lifestyle. Stay tuned for the latest updates and evidence-based solutions to manage and potentially cure this condition.

Episode metadata supplied by the publisher feed · Published May 28, 2025

Embed this episode

NOW PLAYING

The Revolutionary Treatment That Could End Sleep Apnea Forever

0:00 14:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Primary Care Voice?

This episode is 14 minutes long.

When was this Primary Care Voice episode published?

This episode was published on May 28, 2025.

Can I download this Primary Care Voice episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!